HopeStage
Back to all studies
RecruitingNCT05807139

Spironolactone or placebo in adults with alcohol use disorder: a Phase 1b safety study

About this title

Spironolactone in Alcohol Use Disorder (SAUD)

Read the official source — NCT05807139
Medication studyAges 21–99United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 21 years to 99 years.

What will I do during this study?

The protocol describes four separate seven-day clinic stays. Participants take spironolactone capsules during three stays and placebo (an inactive comparison treatment) capsules during one stay. The protocol also includes drinking alcohol under observation and measuring breath and blood alcohol levels.

Listed locations
BaltimoreSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 13, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
20
Sponsor
National Institute on Drug Abuse (NIDA)
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 21 Years to 99 Years
Official registry ID
NCT05807139
Official title
Show the full official title

Spironolactone in Alcohol Use Disorder (SAUD): A Double-Blind, Placebo-Controlled, Ascending Dose, Phase 1b Study

Recruitment & locations

Currently recruiting

Baltimore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What will I need to do?

You will take study medication.

Who is behind this study?

The study sponsor is National Institute on Drug Abuse (NIDA), a research institute.

Does this study involve medication?

Yes. The study involves medication, including Spironolactone.

Who can participate?

Listed age limits: 21 years to 99 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies